A new study co-authored by a Yale economist provides evidence that insufficient antitrust enforcement in the U.S. hospital sector is contributing to reduced competition and higher prices for hospital care.
12 hours ago
0
0
The EU said Thursday it had given the green light for US pharmaceutical giant Pfizer's $43-billion acquisition of biotech firm Seagen, specializing in innovative cancer treatment.
Oct 19, 2023
0
0
Our nation's rural hospitals are struggling. Between 2010 and 2021, almost 140 rural hospitals closed. Additionally, about one-third of the rural hospitals still operating are unprofitable. Rural hospitals struggle financially ...
Jun 16, 2023
0
3
The European Union's anti-trust watchdog announced on Tuesday that it is blocking the buyout of cancer-screening company GRAIL by biotech giant Illumina in a rare move by European regulators against two U.S. companies.
Sep 6, 2022
0
4
Around the world, ventilators—a life-saving medical device that keeps air flowing into the lungs of a patient who is unable to breathe—are a scarce resource in hospitals and clinics where they're used to treat those infected ...
Apr 27, 2020
0
1
The European Commission on Wednesday authorised a merger of US drug giant Pfizer's off-patent business unit with the pharmaceutical company Mylan to create a global powerhouse for lower-cost medicines.
Apr 22, 2020
0
4
Amgen has agreed to acquire the global rights to Otezla, a drug used for the treatment of psoriasis and psoriatic arthritis, for $13.4 billion in cash, Bristol Myers Squibb said Monday.
Aug 26, 2019
0
2
(HealthDay)—Vertical level mergers, which incorporate not just health care providers, but also insurers, retailers, and pharmacy benefit managers (PBMs), could pose challenges in primary care, according to an article published ...
Jun 25, 2018
0
0
Hospital and health system mergers set a record in 2017, with a new report saying networks of care providers bulked up to offer a broader range of services and prepare for new contracts that ask health systems to take financial ...
Jan 31, 2018
0
4
A federal judge has rejected health insurer Aetna's bid to buy rival Humana on grounds that the deal would hurt competition in hundreds of Medicare Advantage markets, ultimately affecting the price consumers pay for coverage.
Jan 23, 2017
0
0
